The Zhongguancun International Technology Trading Conference will be held from April 25th to 29th, 2024, and the "Top 100 New Technologies and Products List" for 2024 will be released at the event venue. The "Recombinant Humanized Anti interleukin-6 Receptor Monoclonal Antibody Injection" project of Weidejie Biotechnology stood out from over 3000 projects and was listed on the list of 100 new technologies and products, creating a new drug list.

      At the Zhongguancun technology trading site, government officials, investors, peer enterprises, CRO companies and other upstream and downstream enterprises, as well as technical association staff who came to participate in the exhibition, stopped in front of the Weidejie booth to learn about projects, consult cooperation and investment. Dr. Zhang Xiaorui, Vice President of the Biopharmaceutical Department of Weidejie, answered questions and explained the company's development and project progress on site.

　　Regarding the 2024 "List of 100 New Technologies and Products"

　　Over three months, more than 3000 projects were publicly solicited from more than 40 countries and regions around the world, including six major fields such as artificial intelligence big data, life science, medicine and health, integrated circuit future communication, and 13 cutting-edge subdivisions such as intelligent manufacturing, innovative drugs, high-end medical equipment, information security aerospace, and unmanned aerial vehicles. After multiple rounds of reviews by 97 academicians, technical experts and investors, 100 new technologies and new products with outstanding performance in innovation, progressiveness, and applicability were selected. Zhongguancun International Technology Trading Conference

　　As an important component of the Zhongguancun Forum, the "Zhongguancun International Technology Trading Conference" was first established in 2020 with the aim of creating a communication and cooperation platform that represents the country and faces the world. It integrates the release and promotion of high-end cutting-edge scientific and technological achievements, supply and demand docking, exchange and negotiation, and publicity and display. It continues to build a technology trading ecosystem and construct a globally influential highland for the transformation of scientific and technological achievements and technology trading.

　　Regarding Weidejie:

　　Beijing VDJBio Co., LTD. is a national high-tech enterprise registered in Haidian District, Beijing, and a specialized and innovative small and medium-sized enterprise in Beijing. Focusing on innovative antibody drug development in the field of autoimmune diseases. With a unique antibody discovery and optimization platform, a complete platform for small, medium, and industrial production of large molecule drugs, a series of antibody/fusion protein drugs with the best potential for treating autoimmune diseases have been developed.